-
Forever chemicals boost multiple sclerosis risk. Is your water safe?
04 Feb 2026 19:44 GMT
Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New research from Sweden links higher levels of per- and polyfluoroalkyl substances, or PFAS, and polychlorinated biphenyls, or PCBs …
-
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
27 Jan 2026 12:30 GMT
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in …
-
Epstein-Barr virus together with a gene variant contributes to onset of multiple sclerosis
13 Jan 2026 19:37 GMT
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role. Researchers at the University of Zurich have now shown that it is the molecular interaction …
-
CIDRAP Op-ed: Vaccine myths that won’t die and how to counter them—part 2
16 Jan 2026 17:23 GMT
… between hepatitis B vaccine and multiple sclerosis. Another study found no evidence … influenza vaccines exacerbated symptoms of multiple sclerosis. Multiple studies have found no … natural immunity is superior to vaccine-induced immunity ignores what “natural …
-
“Absolute Healing” on BrightU: How to heal your gut microbiome and reverse vaccine-induced inflammatory diseases
12 Jan 2026 14:06 GMT
… your gut microbiome and reverse vaccine-induced inflammatory diseases
On Day … , an anesthesiologist who has managed multiple sclerosis for decades, shared his personal …
-
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
15 Dec 2025 06:00 GMT
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated regulatory decision for tolebrutinib is anticipated to be …
-
CDC recommends fewer vaccines as disease among unvaccinated spikes
07 Jan 2026 00:19 GMT
As diseases like measles, whooping cough and tetanus spike in unvaccinated patients, the Centers for Disease Control and Prevention announced a major overhaul to the childhood vaccine schedule, recommending kids get only 11 vaccines instead of 18.
“I think …
-
Column: Fighting dementia could be as easy as the shingles vaccine
26 Dec 2025 14:34 GMT
A relatively mundane middle-aged rite of passage — shingles vaccination — might offer an added benefit: protection against, or even the slowing of the progression of, dementia.
Over the past several years, a growing body of research has suggested that …
-
Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy
24 Dec 2025 11:46 GMT
Sanofi SA (NASDAQ:SNY) on Wednesday agreed to acquire Dynavax Technologies Corporation (NASDAQ:DVAX) for $15.50 per share in cash, reflecting a total equity value of approximately $2.2 billion.
The acquisition augments Sanofi’s presence in adult …
-
Vaccine Panel, Voting to Change Hepatitis B Shot for Newborns, Shares Misleading Information
06 Dec 2025 07:05 GMT
… who has ties to anti-vaccine groups; Cynthia Nevison, an … B vaccine might cause multiple sclerosis, an autoimmune disease in … between the vaccine and “multiple sclerosis and other autoimmune conditions,” … slides read. “While most vaccinees respond well to a …